Connect← Return to This is the $64,000 question. . .WHY NO MED FOR NEUROPATHY?
Discussion
This is the $64,000 question. . .WHY NO MED FOR NEUROPATHY?
Neuropathy | Last Active: Sep 30 5:47pm | Replies (84)Comment receiving replies
@megidigo
The drug WinSanTor is developing is WST-057 (pinzeprine) - you might find more info searching for those terms.
Here is the latest I could find:
https://www.pfsfoundation.org/news/rushing-to-relieve-peripheral-neuropathy-winsantor-ditches-fdas-compassionate-use-program-and-goes-directly-to-the-state-with-americas-most-permissive-right-to-try-laws/
It appears the corporation has chosen to bypass the FDA required Phase III trials, so who knows what the future may be for this treatment?
Replies to "@megidigo The drug WinSanTor is developing is WST-057 (pinzeprine) - you might find more info searching..."
Connect
@sueinmn
Not to appear rude but
They are not bypassing Phase 3 trials they are shifting away from the FDA’s Expanded Access Program (aka compassionate use) to Montanas Right to Try Program.
As per the link you provided (i also posted it earlier) and the info I received directly from them in an email from Winsantor regarding phase 3 trials:
“ In parallel, we are pursuing conditional approval in the Canadian market and continuing our Phase 3 program in the US.”
“ In the case of WST-057, the drug has already completed Phase 1 and Phase 2 trials, and is currently in the final development stages of Phase 3 trials.”.
The future is the Right to Try Program in Montana.
If that happens I suppose.